EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SGLT2 inhibitors in type 2 diabetes: a comprehensive review of their effects on the autonomic nervous system and cardiovascular health

Dominik Zając, Jakub Jucha, Ilie Lastovestkyi, Beata Bujak-Giżycka, Barbara Lorkowska-Zawicka

Folia Medica Cracoviensia · 2025

DOI: 10.24425/fmc.2025.156687 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Folia Medica Cracoviensia, 2025. Verfasst von Dominik Zając und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Scientific Group of Clinical Pharmacology, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Autonomic Nervous System, Cardiovascular Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are antidiabetic drugs that help lower high blood sugar levels by blocking the reabsorption of glucose in the kidneys. Although their primary function is to control blood sugar in type 2 diabetes mellitus (T2DM), growing evidence suggests they may also have additional benefits, particularly in reducing neurological and cardiovascular complications related to T2DM. This study explores the neuroprotective effects of SGLT2i, which appear to improve symptoms of peripheral neuropathy by enhancing nerve conduction for both sensory and motor functions and reducing neuropathic pain. These effects are believed to occur through mechanisms such as the activation of AMP-activated protein kinase and the reduction of mitogen-activated protein kinase phosphorylation, both of which protect nerve function. In terms of cardiovascular health, SGLT2i show cardioprotective effects by lowering sympathetic nervous system activity, reducing blood pressure, and minimizing the risk of heart failure-related hospitalizations and arrhythmias. Furthermore, these inhibitors may play a role in preventing diabetic retinopathy by reducing oxidative stress and blocking inflammatory pathways in retinal tissue. Although some research has hinted at a potential link between SGLT2i use and increased risk of diabetic foot complications, the results are not definitive and require further study. Overall, SGLT2 inhibitors represent a multifaceted approach in managing T2DM, offering additional neurological and cardiovascular benefits. Ongoing research is critical to fully understand their mechanisms, enhance therapeutic outcomes, and confirm their safety for a wide range of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsAutonomic Nervous SystemCardiovascular DiseasesHypoglycemic AgentsCardiovascular SystemHumansDiabetic Neuropathies

Stichwörter der Autor:innen

SGLT2 inhibitorsautonomic nervous systemcardiovascular healthglucose reabsorptionneuroprotectiontype 2 diabetes

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents

Autor:innen und Institutionen

  • Student Scientific Group of Clinical Pharmacology, Jagiellonian University Medical College, Kraków, Poland.
  • Department of Clinical Pharmacology, Chair of Pharmacology, Jagiellonian University Medical College, Kraków, Poland. beata.bujak-gizycka@uj.edu.pl.
  • Department of Clinical Pharmacology, Chair of Pharmacology, Jagiellonian University Medical College, Kraków, Poland.

Zitieren

APA

Zając, D., Jucha, J., Lastovestkyi, I., Bujak-Giżycka, B., & Lorkowska-Zawicka, B. (2025). SGLT2 inhibitors in type 2 diabetes: a comprehensive review of their effects on the autonomic nervous system and cardiovascular health. Folia Medica Cracoviensia. https://doi.org/10.24425/fmc.2025.156687

Vancouver

Zając D, Jucha J, Lastovestkyi I, Bujak-Giżycka B, Lorkowska-Zawicka B. SGLT2 inhibitors in type 2 diabetes: a comprehensive review of their effects on the autonomic nervous system and cardiovascular health. Folia Medica Cracoviensia. 2025. doi:10.24425/fmc.2025.156687

BibTeX
@article{Zajc2025,
  author = {Zając, Dominik and Jucha, Jakub and Lastovestkyi, Ilie and Bujak-Giżycka, Beata and Lorkowska-Zawicka, Barbara},
  title = {SGLT2 inhibitors in type 2 diabetes: a comprehensive review of their effects on the autonomic nervous system and cardiovascular health},
  journal = {Folia Medica Cracoviensia},
  year = {2025},
  doi = {10.24425/fmc.2025.156687}
}
Kostenlos starten →